Placebo: Normal Saline - Solution for injection clinical trials

A Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to investigate the efficacy and safety of daxdilimab subcutaneous injection in reducing disease activity in adult participants with moderate-to-severe primary discoid lupus erythematosus.

This study is looking into a new medication called daxdilimab for adults with a type of lupus called discoid lupus erythematosus. Researchers want to see if this medicine can improve skin symptoms and if it's safe to use compared to a dummy treatment.